BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38151580)

  • 1. Neoadjuvant Therapies Do Not Reduce Epidermal Growth Factor Receptor (EGFR) Expression or EGFR-Targeted Fluorescence in a Murine Model of Soft-Tissue Sarcomas.
    Streeter SS; Xu X; Hebert KA; Werth PM; Hoopes PJ; Jarvis LA; Pogue BW; Paulsen KD; Samkoe KS; Henderson ER
    Mol Imaging Biol; 2024 Apr; 26(2):272-283. PubMed ID: 38151580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.
    Samkoe KS; Sardar HS; Bates BD; Tselepidakis NN; Gunn JR; Hoffer-Hawlik KA; Feldwisch J; Pogue BW; Paulsen KD; Henderson ER
    J Surg Oncol; 2019 Jun; 119(8):1077-1086. PubMed ID: 30950072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of preoperative cancer treatment on epidermal growth factor receptor (EGFR) receptor expression level in ABY-029 guided sarcoma surgery.
    Xu X; Samkoe KS; Henderson ER
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 32483396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-targeted fluorescence is unaffected by standard neoadjuvant therapies in human sarcomas.
    Henderson ER; Werth P; Xu X; Jarvis LA; Paulsen KD; Hoopes PJ; Rosenthal EL; Pogue BW; Samkoe KS
    Proc SPIE Int Soc Opt Eng; 2022; 119430():. PubMed ID: 36052271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
    Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
    Samkoe KS; Gunn JR; Marra K; Hull SM; Moodie KL; Feldwisch J; Strong TV; Draney DR; Hoopes PJ; Roberts DW; Paulsen K; Pogue BW
    Mol Imaging Biol; 2017 Aug; 19(4):512-521. PubMed ID: 27909986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.
    Wang C; Xu X; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
    Mol Imaging Biol; 2023 Feb; 25(1):97-109. PubMed ID: 34642897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-agent fluorescent labeling of soft-tissue sarcomas improves the contrast based upon targeting both interstitial and cellular components of the tumor milieu.
    Sardar HS; Zai Q; Xu X; Gunn JR; Pogue BW; Paulsen KD; Henderson ER; Samkoe KS
    J Surg Oncol; 2020 Dec; 122(8):1711-1720. PubMed ID: 32885452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.
    Wang C; Xu X; Folaron M; Gunn JR; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
    Mol Imaging Biol; 2023 Feb; 25(1):110-121. PubMed ID: 34651290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors.
    Mahalingam SM; Dudkin VY; Goldberg S; Klein D; Yi F; Singhal S; O'Neil KT; Low PS
    Bioconjug Chem; 2017 Nov; 28(11):2865-2873. PubMed ID: 28945346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of chemo- and radiotherapy on tumor necrosis in soft tissue sarcoma- does it influence prognosis?
    Fromm J; Klein A; Kirilova M; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
    BMC Cancer; 2024 Mar; 24(1):303. PubMed ID: 38448852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zwitterionic near-infrared fluorophore-conjugated epidermal growth factor for fast, real-time, and target-cell-specific cancer imaging.
    Kim H; Cho MH; Choi HS; Lee BI; Choi Y
    Theranostics; 2019; 9(4):1085-1095. PubMed ID: 30867817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
    Samkoe KS; Sardar HS; Gunn J; Feldwisch J; Linos K; Henderson E; Pogue B; Paulsen K
    Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 31595101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore.
    Gong H; Kovar J; Little G; Chen H; Olive DM
    Neoplasia; 2010 Feb; 12(2):139-49. PubMed ID: 20126472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare.
    Cascio MJ; O'Donnell RJ; Horvai AE
    Mod Pathol; 2010 Apr; 23(4):574-80. PubMed ID: 20118913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue.
    Li C; Mi J; Wang Y; Zhang Z; Guo X; Zhou J; Hu Z; Tian J
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):494-507. PubMed ID: 36207638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence Lifetime-Based Tumor Contrast Enhancement Using an EGFR Antibody-Labeled Near-Infrared Fluorophore.
    Pal R; Kang H; Choi HS; Kumar ATN
    Clin Cancer Res; 2019 Nov; 25(22):6653-6661. PubMed ID: 31481509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors.
    Gong H; Kovar JL; Cheung L; Rosenthal EL; Olive DM
    Cancer Biol Ther; 2014 Feb; 15(2):185-93. PubMed ID: 24100437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging.
    Wang K; Wang K; Li W; Huang T; Li R; Wang D; Shen B; Chen X
    Acta Radiol; 2009 Dec; 50(10):1095-103. PubMed ID: 19922304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.